-- Israeli Life-Science Companies Raise Most Funds in Two Years
-- B y   D a v i d   W a i n e r
-- 2012-05-14T09:34:06Z
-- http://www.bloomberg.com/news/2012-05-14/israeli-life-science-companies-raise-most-funds-in-two-years.html
Israeli biomedical companies
attracted the most  venture capital  in two years during the first
quarter, according to the IVC-KPMG Quarterly Survey.  The survey showed 38 health-related companies raised a
total of $130 million, 2 percent more than in the same period
last year and 73 percent more than in the fourth quarter, IVC-
KPMG said in a statement today. Biomedical funds constituted 27
percent of all the venture capital money raised this quarter,
the most out of any industry, according to  IVC-KPMG .  Funds specializing on life sciences have boosted their
investment focus on  Israel . OrbiMed, an investment management
firm focused on health-care, said on April 23 it started a $222
million fund investing in on Israeli life sciences. Israeli
venture capital fund Pontifax Ltd.  raised $88 million  for a
health fund last year.  Israel’s  biotechnology index  has gained 8.9 percent since
the start of the year, outperforming the benchmark TA-25 index’s
2.6 percent return.  To contact the reporter on this story:
David Wainer in  Tel Aviv  at 
 dwainer3@bloomberg.net   To contact the editor responsible for this story:
Phil Serafino at 
 pserafino@bloomberg.net  